| Patent | Date |
|---|
Antibodies with low immunogenicity and uses thereof
Grant 11,427,632 - Johnson , et al. August 30, 2 | 2022-08-30 |
BCMA-binding antibodies and uses thereof
Grant 11,401,336 - Abbasian , et al. August 2, 2 | 2022-08-02 |
Engineering Of An Antibody For Tumor-selective Binding Of Cd47
App 20220162330 - HADJIVASSILIOU; Haralambos ; et al. | 2022-05-26 |
Cd47 Antibodies And Methods Of Use Thereof
App 20210371522 - Sung; Victoria ; et al. | 2021-12-02 |
Bcma-binding Antibodies And Uses Thereof
App 20200399386 - Abbasian; Mahan ; et al. | 2020-12-24 |
Methods And Compositions For Reduction Of Immunogenicity
App 20200330590 - Johnson; Jeffrey C. ; et al. | 2020-10-22 |
Pd-1 Binding Proteins And Methods Of Use Thereof
App 20200255525 - Kind Code | 2020-08-13 |
Cd47 Antibodies And Methods Of Use Thereof
App 20200255515 - Kind Code | 2020-08-13 |
SIRP-Alpha BINDING PROTEINS AND METHODS OF USE THEREOF
App 20200102387 - Abbasian; Mahan ; et al. | 2020-04-02 |
PD-1 binding proteins and methods of use thereof
Grant 10,428,145 - Bennett , et al. October 1, 2 | 2019-10-01 |
Antibodies With Low Immunogenicity And Uses Thereof
App 20190241654 - JOHNSON; Jeffrey C. ; et al. | 2019-08-08 |
Pd-1 Binding Proteins And Methods Of Use Thereof
App 20170088618 - Bennett; Brydon ; et al. | 2017-03-30 |
Non-fucosylated Antibodies
App 20130183288 - Reff; Mitchell ; et al. | 2013-07-18 |
Anti-IGR-1R antibodies and uses thereof
Grant 8,147,829 - Hariharan , et al. April 3, 2 | 2012-04-03 |
Modulation Of Tumor Microenvironment
App 20100203010 - Hariharan; Kandasamy ; et al. | 2010-08-12 |
Treatment Of Hodgkins Lymphoma
App 20100189716 - Molina; Arturo ; et al. | 2010-07-29 |
Anti-IGF-1R Antibodies and Uses Thereof
App 20100098710 - Hariharan; Kandasamy ; et al. | 2010-04-22 |
Anti-IGF-1R Antibodies and Uses Thereof
App 20100099147 - Hariharan; Kandasamy ; et al. | 2010-04-22 |
Therapeutic Combinations Of Anti-igf-1r Antibodies And Other Compounds
App 20090291088 - Hariharan; Kandasamy ; et al. | 2009-11-26 |
Anti-IGF-1R antibodies and uses thereof
Grant 7,612,178 - Hariharan , et al. November 3, 2 | 2009-11-03 |
Compositions That Bind Multiple Epitopes Of Igf-1r
App 20090130105 - Glaser; Scott ; et al. | 2009-05-21 |
Anti-IGF-1R Antibodies and Uses Thereof
App 20090092614 - Demarest; Stephen ; et al. | 2009-04-09 |
Immunoregulatory Antibodies And Uses Thereof
App 20080226626 - Hariharan; Kandasamy ; et al. | 2008-09-18 |
Immunoregulatory Antibodies And Uses Thereof
App 20080227198 - Hariharan; Kandasamy ; et al. | 2008-09-18 |
Use Of Cd23 Antagonists For The Treatment Of Neoplastic Disorders
App 20080213167 - Hariharan; Kandasamy ; et al. | 2008-09-04 |
Use Of Cd23 Antagonists For The Treatment Of Neoplastic Disorders
App 20080213168 - Hariharan; Kandasamy ; et al. | 2008-09-04 |
Use Of Cd23 Antagonists For The Treatment Of Neoplastic Disorders
App 20080213260 - Hariharan; Kandasamy ; et al. | 2008-09-04 |
Use Of Cd23 Antagonists For The Treatment Of Neoplastic Disorders
App 20080171056 - Hariharan; Kandasamy ; et al. | 2008-07-17 |
TAG-72 specific C.sub.H2 domain deleted antibodies
Grant 7,319,139 - Braslawsky , et al. January 15, 2 | 2008-01-15 |
Tag-72 Specific Ch2 Domain Deleted Antibodies
App 20070280881 - Braslawsky; Gary R. ; et al. | 2007-12-06 |
Anti-IGF-1R antibodies and uses thereof
App 20070243194 - Hariharan; Kandasamy ; et al. | 2007-10-18 |
Anti-cd80 Antibody Having Adcc Activity For Adcc Mediated Killing Of B Cell Lymphoma Cells Alone Or In Combination With Other Therapies
App 20070065436 - Hariharan; Kandasamy ; et al. | 2007-03-22 |
Immunoregulatory Antibodies and Uses Thereof
App 20070009519 - Hariharan; Kandasamy ; et al. | 2007-01-11 |
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
App 20060286100 - Hariharan; Kandasamy ; et al. | 2006-12-21 |
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
App 20060286101 - Hariharan; Kandasamy ; et al. | 2006-12-21 |
Use Of Cd23 Antagonists For The Treatment Of Neoplastic Disorders
App 20060171950 - Hariharan; Kandasamy ; et al. | 2006-08-03 |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
App 20060153848 - Hanna; Nabil ; et al. | 2006-07-13 |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
Grant 6,998,125 - Hanna , et al. February 14, 2 | 2006-02-14 |
Production of tetravalent antibodies
App 20050158828 - Braslawsky, Gary R. ; et al. | 2005-07-21 |
Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
App 20050123540 - Hanna, Nabil ; et al. | 2005-06-09 |
Production of tetravalent antibodies
Grant 6,897,044 - Braslawsky , et al. May 24, 2 | 2005-05-24 |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
App 20040137014 - Hanna, Nabil ; et al. | 2004-07-15 |
Use of CD23 antagonists for the treatment of neoplastic disorders
App 20030211107 - Hariharan, Kandasamy ; et al. | 2003-11-13 |
Anti-CD80 antibody having ADCC activity for ADCC mediated killing of B cell lymphoma cells alone or in combination with other therapies
App 20030180290 - Hariharan, Kandasamy ; et al. | 2003-09-25 |
Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy
App 20030180292 - Hanna, Nabil ; et al. | 2003-09-25 |
Immunoregulatory antibodies and uses thereof
App 20030103971 - Hariharan, Kandasamy ; et al. | 2003-06-05 |
Use of CD23 antagonists for the treatment of neoplastic disorders
App 20020159996 - Hariharan, Kandasamy ; et al. | 2002-10-31 |
Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
App 20020028178 - Hanna, Nabil ; et al. | 2002-03-07 |
Treatment of cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
App 20020006404 - Hanna, Nabil ; et al. | 2002-01-17 |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
App 20010019715 - Hanna, Nabil ; et al. | 2001-09-06 |
Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy
App 20010018041 - Hanna, Nabil ; et al. | 2001-08-30 |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
App 20010018054 - Hanna, Nabil ; et al. | 2001-08-30 |
| 